ResMed Inc. Equity Method Investment, Other than Temporary Impairment
ResMed Inc. (RMD) reported Equity Method Investment, Other than Temporary Impairment of $7.41 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-08-13
- ResMed Inc. equity method investment, other than temporary impairment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ResMed Inc. equity method investment, other than temporary impairment for the quarter ending 2026-03-31 was $6.28M, a 109.37% increase year-over-year.
- ResMed Inc. equity method investment, other than temporary impairment for the quarter ending 2025-12-31 was $0.00.
- ResMed Inc. equity method investment, other than temporary impairment for the quarter ending 2025-09-30 was $1.13M, a 78.55% decline year-over-year.
- ResMed Inc. equity method investment, other than temporary impairment for fiscal 2026 was $7.41M, a 36.90% decline from fiscal 2025.
- ResMed Inc. equity method investment, other than temporary impairment for fiscal 2025 was $11.74M, a 136.59% increase from fiscal 2024.
- ResMed Inc. equity method investment, other than temporary impairment for fiscal 2024 was $4.96M, a 1.45% increase from fiscal 2023.
- ResMed Inc. equity method investment, other than temporary impairment for fiscal 2023 was $4.89M.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-13 | $6.28M derived: sum of 2 quarters · filed 2026-08-13 | $6.28M derived: sum of 3 quarters · filed 2026-08-13 | $7.41M 10-K · filed 2026-08-13 |
| 2026-03-31 | $6.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-01 | $6.28M derived: sum of 2 quarters · filed 2026-05-01 | $7.41M 10-Q · filed 2026-05-01 | $10.89M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-30 | $1.13M 10-Q · filed 2026-01-30 | $4.61M derived: sum of 3 quarters · filed 2026-08-13 | $7.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $1.13M 10-Q · filed 2025-10-31 | $4.61M derived: sum of 2 quarters · filed 2026-08-13 | $7.61M derived: sum of 3 quarters · filed 2026-08-13 | $7.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-13 | $6.48M derived: sum of 2 quarters · filed 2026-08-13 | $6.48M derived: sum of 3 quarters · filed 2026-08-13 | $11.74M 10-K · filed 2026-08-13 |
| 2025-03-31 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-01 | $3.00M derived: sum of 2 quarters · filed 2026-05-01 | $8.26M 10-Q · filed 2026-05-01 | $13.22M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-30 | $5.26M 10-Q · filed 2026-01-30 | $10.22M derived: sum of 3 quarters · filed 2026-01-30 | |
| 2024-09-30 | $5.26M 10-Q · filed 2025-10-31 | $10.22M derived: sum of 2 quarters · filed 2025-10-31 | ||
| 2024-06-30 | $4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-08 | $4.96M 10-K · filed 2025-08-08 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-04-26 | |||
| 2023-06-30 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-09 | $4.89M 10-K · filed 2024-08-09 | ||
| 2023-03-31 | $3.00M 10-Q · filed 2024-04-26 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-28 | $0.00 derived: sum of 2 quarters · filed 2023-04-28 | $209.00K 10-Q · filed 2023-04-28 | |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-27 | $209.00K 10-Q · filed 2023-01-27 | ||
| 2021-09-30 | $209.00K 10-Q · filed 2022-10-28 |